NCT04616066

Brief Summary

Dried dates (Phoenix dactylifera) have the second highest phytoestrogen content of any fruit, only secondary to dried apricots with 329ug of phytoestrogens per 100g. The date palm is one of oldest planted trees on the earth at around 2,000 years old. Dates are nutritionally rich and a good source of fiber and carbohydrates and their potential medicinal and nutritional effects have been suggested in a number of studies. Date sugars have also been shown to be phenol rich, potent antioxidant, and strong inhibitor of α -glycosidase that may also have benefit in diabetes. In addition, dates are rich in micronutrients that may also have benefit for diabetes and insulin resistance . Dates have a glycemic index of 50 and studies have shown that the consumption of differing varieties of dates do not significantly affect the acute glycemia in patients with type 2 diabetes. The objective of this study is to investigate the effect of date phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes in comparison to the same glycemic load of raisins that have low phytoestrogen content.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
79

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2020

Completed
10 days until next milestone

First Posted

Study publicly available on registry

November 4, 2020

Completed
11 months until next milestone

Study Start

First participant enrolled

October 10, 2021

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2022

Completed
Last Updated

October 4, 2022

Status Verified

October 1, 2022

Enrollment Period

7 months

First QC Date

October 25, 2020

Last Update Submit

October 3, 2022

Conditions

Keywords

Type2 diabetesDatesPhytoestrogen

Outcome Measures

Primary Outcomes (1)

  • The effect of phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes

    Measuring the levels of phytoestrogen and evaluate if it has reduced the average blood sugar levels over a period of 3 months.

    90 days

Secondary Outcomes (2)

  • Determine whether date phytoestrogens affect cardiovascular risk

    90 days

  • Determine whether date phytoestrogens affect insulin resistance

    90 days

Study Arms (2)

Dates Arm

EXPERIMENTAL

Consumption of Khalas dates (3 dates =30g undried dates) twice daily (phytoestrogen content 329ug/100g)

Other: Dates

Raisins Arm

EXPERIMENTAL

Consumption of Raisins (30g twice daily, phytoestrogen content of 9.6ug/100g)

Other: Raisins

Interventions

DatesOTHER

The effect of date phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes

Dates Arm
RaisinsOTHER

The effect of raisins phytoestrogens on HbA1C and fasting blood glucose in patients with type 2 diabetes

Raisins Arm

Eligibility Criteria

Age45 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • The diagnosis of type 2 diabetes will be based on the WHO guidelines. An HbA1C of 6.5% or greater, or 2 fasting plasma glucose readings of \>7.0mmoll-1 or 2 random plasma glucose readings \>11mmoll-1 in the absence of symptoms or concurrent illness or medication which might lead to hyperglycaemia (e.g. thiazide diuretics). Or one reading meets the diagnostic level with the presence of symptoms of polyuria, polydipsia, nocturia, fatigue or blurring of vision. The final diagnostic method of diagnosis type 2 diabetes is a positive oral glucose tolerance test (OGTT) using a 75g glucose load. If doubt exists on the diagnosis of diabetes an OGTT will be performed.
  • Patients will be on stable medication for their diabetes, hypertension, lipids and gout (if appropriate) for 3 months prior to entry into the study.
  • HbA1c 7.5 - 10%
  • Patients between the ages of 45-75 years at the start of the study.
  • Capable to give informed consent and complete the study.

You may not qualify if:

  • Patients with concurrent illness or any medication in the last 3 months.
  • Patients who are taking hormone replacement therapy.
  • Patients who are currently or have taken antibiotics in the last 3 months.
  • Currently enrolled in other clinical trials.
  • Hba1c at recruiting stage of more than 10%.
  • Patients with a BMI less than 20 and more than 40.
  • Patients with known food allergies.
  • Patients on insulin.
  • Patients who are eating dates or raisins should be washed out for 4 weeks.
  • Pregnant or nursing, or plans to become pregnant in the next 3 months, or not using adequate contraceptive measures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal College of Surgeons in Ireland - Bahrain

Manama, Bahrain

Location

Related Publications (12)

  • Xiao CW. Health effects of soy protein and isoflavones in humans. J Nutr. 2008 Jun;138(6):1244S-9S. doi: 10.1093/jn/138.6.1244S.

    PMID: 18492864BACKGROUND
  • Jayagopal V, Albertazzi P, Kilpatrick ES, Howarth EM, Jennings PE, Hepburn DA, Atkin SL. Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes. Diabetes Care. 2002 Oct;25(10):1709-14. doi: 10.2337/diacare.25.10.1709.

    PMID: 12351466BACKGROUND
  • Xu SZ, Zeng B, Daskoulidou N, Chen GL, Atkin SL, Lukhele B. Activation of TRPC cationic channels by mercurial compounds confers the cytotoxicity of mercury exposure. Toxicol Sci. 2012 Jan;125(1):56-68. doi: 10.1093/toxsci/kfr268. Epub 2011 Oct 9.

    PMID: 21984481BACKGROUND
  • Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N. Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan. Nutr Cancer. 2006;54(2):184-201. doi: 10.1207/s15327914nc5402_5.

    PMID: 16898863BACKGROUND
  • Vayalil PK. Date fruits (Phoenix dactylifera Linn): an emerging medicinal food. Crit Rev Food Sci Nutr. 2012;52(3):249-71. doi: 10.1080/10408398.2010.499824.

    PMID: 22214443BACKGROUND
  • Hamad I, AbdElgawad H, Al Jaouni S, Zinta G, Asard H, Hassan S, Hegab M, Hagagy N, Selim S. Metabolic Analysis of Various Date Palm Fruit (Phoenix dactylifera L.) Cultivars from Saudi Arabia to Assess Their Nutritional Quality. Molecules. 2015 Jul 27;20(8):13620-41. doi: 10.3390/molecules200813620.

    PMID: 26225946BACKGROUND
  • Alkaabi JM, Al-Dabbagh B, Ahmad S, Saadi HF, Gariballa S, Ghazali MA. Glycemic indices of five varieties of dates in healthy and diabetic subjects. Nutr J. 2011 May 28;10:59. doi: 10.1186/1475-2891-10-59.

    PMID: 21619670BACKGROUND
  • Alkaabi J, Al-Dabbagh B, Saadi H, Gariballa S, Yasin J. Effect of traditional Arabic coffee consumption on the glycemic index of Khalas dates tested in healthy and diabetic subjects. Asia Pac J Clin Nutr. 2013;22(4):565-73. doi: 10.6133/apjcn.2013.22.4.09.

    PMID: 24231017BACKGROUND
  • Miller CJ, Dunn EV, Hashim IB. The glycaemic index of dates and date/yoghurt mixed meals. Are dates 'the candy that grows on trees'? Eur J Clin Nutr. 2003 Mar;57(3):427-30. doi: 10.1038/sj.ejcn.1601565.

    PMID: 12627179BACKGROUND
  • Senn SJ. Covariate imbalance and random allocation in clinical trials. Stat Med. 1989 Apr;8(4):467-75. doi: 10.1002/sim.4780080410.

    PMID: 2727470BACKGROUND
  • Senn S. Testing for baseline balance in clinical trials. Stat Med. 1994 Sep 15;13(17):1715-26. doi: 10.1002/sim.4780131703.

    PMID: 7997705BACKGROUND
  • Knol MJ, Groenwold RH, Grobbee DE. P-values in baseline tables of randomised controlled trials are inappropriate but still common in high impact journals. Eur J Prev Cardiol. 2012 Apr;19(2):231-2. doi: 10.1177/1741826711421688. No abstract available.

    PMID: 22512015BACKGROUND

MeSH Terms

Interventions

Chronology as Topic

Intervention Hierarchy (Ancestors)

TimePhysical Phenomena

Study Officials

  • Naji Alamuddin, Dr.

    Royal College of Surgeons in Ireland - Bahrain

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This is a parallel, prospective, interventional and randomized trial involving 80 patients with type 2 diabetes. They will be randomised to either 60g of dates or 60g of raisins (amount split and given as a mid-morning and mid-afternoon snack) for 3 months.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 25, 2020

First Posted

November 4, 2020

Study Start

October 10, 2021

Primary Completion

April 30, 2022

Study Completion

May 30, 2022

Last Updated

October 4, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

Monitoring, audits, and REC review will be permitted and provide direct access to source data and documents. The Lead PI and the researchers assigned by him will have access to the stored data/specimens. Only the Lead PI and the researchers assigned working on this study will be eligible to obtain the data/specimens from the participants during data collection.

Shared Documents
STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
Time Frame
Dr Naji will act as the data custodian and is responsible for the storage, handling and quality of the study data. Data will be collected in the case report form to allow for cross referencing to check validity. Study documents (paper and electronic) will be retained in a secure (kept locked when not in use) location during and after the trial has finished. All essential documents including source documents will be retained for a period of 3 years after study completion (last patient, last study point). A label stating the date after which the documents can be destroyed will be placed on the inside front cover of the case notes of trial participants.
Access Criteria
Study documents (paper and electronic) will be retained in a secure (kept locked when not in use) location during and after the trial has finished.

Locations